sotagliflozin · Powder

What changed in the last 90 days

Every detected change for sotagliflozin, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Sodium-Glucose Cotransporter 2 Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

• dapagliflozin and saxagliptin· 1 maker
• empagliflozin and linagliptin· 1 maker
• empagliflozin, linagliptin, metformin hydrochloride· 1 maker
• empagliflozin, metformin hydrochloride· 1 maker
• canagliflozin and metformin hydrochloride· 2 makers
• empagliflozin and metformin hydrochloride· 2 makers
• bexagliflozin· 3 makers
• dapagliflozin and metformin hydrochloride· 9 makers
• canagliflozin· 12 makers
• empagliflozin· 31 makers
• dapagliflozin· 40 makers

Common questions

Is Sotagliflozin in shortage right now?

No. FDA does not currently list Sotagliflozin in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.

Who makes Sotagliflozin?

2 companies have marketed Sotagliflozin in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

What does Sotagliflozin cost?

The typical pharmacy pays about $20.46 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.